MyFinsight
Home
Blog
About
Marketable securities
$866,355K
(127.25%↑ Y/Y)
Cash and cash
equivalents
$105,571K
(-14.99%↓ Y/Y)
Prepaid expenses and
other current assets
$19,807K
(85.08%↑ Y/Y)
Total current assets
$991,733K
(92.15%↑ Y/Y)
Long-term marketable
securities
$321,943K
(178.09%↑ Y/Y)
Other non-current
assets
$10,607K
(19.76%↑ Y/Y)
Right-of-use asset, net
$6,708K
(-36.63%↓ Y/Y)
Property and equipment,
net
$4,822K
(-25.10%↓ Y/Y)
Total assets
$1,335,813K
(103.08%↑ Y/Y)
Total liabilities and
stockholders' equity
$1,335,813K
(103.08%↑ Y/Y)
Total stockholders'
equity
$1,194,604K
(92.86%↑ Y/Y)
Total liabilities
$141,209K
(268.01%↑ Y/Y)
Accumulated deficit
-$721,724K
(-68.88%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$2,503K
(-465.40%↓ Y/Y)
Additional paid-in capital
$1,918,830K
(83.43%↑ Y/Y)
Revenue share liability
$99,231K
Total current
liabilities
$37,510K
(18.89%↑ Y/Y)
Lease liability, net
of current
$4,468K
(-34.49%↓ Y/Y)
Common stock 0.00001
par value,...
$1K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$32,065K
(46.76%↑ Y/Y)
Accounts payable
$3,080K
(-45.76%↓ Y/Y)
Lease liability
$2,365K
(-41.24%↓ Y/Y)
Back
Back
Balance Sheet
Apogee Therapeutics, Inc. (APGE)
Apogee Therapeutics, Inc. (APGE)
source: myfinsight.com